Private equity titan Carlyle has backed clinical trial data management business Saama Technologies to expand its go-to-market capabilities and further investment in AI research and development.
The post Carlyle buys into AI-embedded clinical trial data management business Saama Technologies alongside healthcare-focused funds first appeared on AltAssets Private Equity News.
